What is testosterone screening, and why is the U.S. military introducing it? | Explained
The U.S. Department of Defense has mandated annual testosterone screening for active-duty service members aged 30 and older. The policy aims to improve troop health and readiness, though it has sparked debate regarding its alignment with existing policies for transgender personnel.
Why it matters
This policy change impacts military medical standards and has become a point of contention in broader political discussions about gender-affirming care.
The U.S. Department of Defense has announced mandatory annual testosterone screening for all active-duty service members aged 30 years and above. Announced by U.S. Defence Secretary Pete Hegseth on July 15, the policy will make testosterone testing part of routine annual medical assessments. Personnel found to have low testosterone may undergo further clinical evaluation and can choose whether to receive testosterone replacement therapy (TRT), while those below 30 years may request testing voluntarily.
The article presents the military's stated goals alongside the political concerns raised by lawmakers.
Get smarter about the news
Sign up free for a feed built around what you actually care about, Dive Deeper research on any story, and the full text of every article.
Create free accountAlready have an account? Sign in